OR Royalties Inc. $OR is U S Global Investors Inc.’s 5th Largest Position

U S Global Investors Inc. grew its holdings in OR Royalties Inc. (NYSE:OR) by 62.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 931,076 shares of the basic materials company’s stock after acquiring an additional 356,245 shares during the period. OR Royalties comprises approximately 4.2% of U S Global Investors Inc.’s holdings, making the stock its 5th biggest holding. U S Global Investors Inc. owned about 0.49% of OR Royalties worth $37,312,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in OR. Hsbc Holdings PLC acquired a new stake in OR Royalties in the 1st quarter valued at $208,000. Trexquant Investment LP acquired a new position in shares of OR Royalties during the first quarter worth about $248,000. Cubist Systematic Strategies LLC purchased a new stake in shares of OR Royalties in the first quarter worth about $1,910,000. Amundi grew its stake in shares of OR Royalties by 24.6% in the first quarter. Amundi now owns 1,083,434 shares of the basic materials company’s stock valued at $22,730,000 after buying an additional 213,939 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of OR Royalties by 13.1% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,770,679 shares of the basic materials company’s stock valued at $79,566,000 after buying an additional 435,467 shares during the period. Institutional investors and hedge funds own 68.52% of the company’s stock.

Analyst Ratings Changes

OR has been the subject of a number of analyst reports. Canaccord Genuity Group upgraded OR Royalties from a “hold” rating to a “strong-buy” rating in a report on Wednesday, October 22nd. Raymond James Financial raised shares of OR Royalties from a “market perform” rating to an “outperform” rating and set a $41.00 target price on the stock in a research report on Thursday, November 6th. Jefferies Financial Group restated a “hold” rating and issued a $38.00 target price on shares of OR Royalties in a research note on Sunday, December 7th. Wall Street Zen raised shares of OR Royalties from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of OR Royalties in a report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, OR Royalties presently has an average rating of “Moderate Buy” and a consensus price target of $35.75.

OR Royalties Price Performance

OR opened at $35.14 on Friday. The stock has a market capitalization of $6.61 billion, a PE ratio of 44.48 and a beta of 0.78. The firm’s fifty day moving average price is $34.01 and its 200 day moving average price is $32.66. OR Royalties Inc. has a 12-month low of $17.55 and a 12-month high of $42.25.

OR Royalties (NYSE:OR) last announced its quarterly earnings data on Wednesday, November 5th. The basic materials company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.03. The company had revenue of $71.63 million during the quarter, compared to analyst estimates of $53.85 million. OR Royalties had a net margin of 60.72% and a return on equity of 10.67%. On average, equities research analysts forecast that OR Royalties Inc. will post 0.62 earnings per share for the current fiscal year.

OR Royalties Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Wednesday, December 31st will be issued a $0.055 dividend. This represents a $0.22 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Wednesday, December 31st. OR Royalties’s payout ratio is currently 27.85%.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.